Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case Western Reserve University and University Hospitals shows some promising results. The study, published in BMC Medicine, found that a specially engineered immune-cell treatment, called OSM CAR-T, successfully attacks osteosarcoma tumors in mouse models.
This article was originally published on MedicalXpress.com
